KERX Financial Facts

Interest and other income, net: 150K
Income taxes: 20K
See Full Income Statement

Total liabilities and stockholders' equity: 168.63M
Accrued compensation and related liabilities: 4.92M
See Full Balance Sheet

Keryx Biopharmaceuticals Inc. (KERX) Earnings

  |   Expand Research on KERX
Next EPS Date 2/24/17 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -59.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +8.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/8/11 Q410 -$0.09-$0.06 -$0.03N/A$2.82M N/A Details
5/8/12 Q112 -$0.13-$0.12 -$0.01N/AN/A N/A Details
2/25/16 Q415 -$0.36-$0.25 -$0.11$5.8M$5.68M N/A Details
11/9/16 Q316 -$0.39-$0.20 -$0.19$6.3M$5.37M N/A Details
2/29/12 Q411 -$0.12-$0.14 +$0.02N/AN/A N/A Details
11/4/13 Q313 -$0.19-$0.11 -$0.08N/A$2.22M N/A Details
2/27/15 Q414 -$0.44-$0.37 -$0.07$569K$1.39M N/A Details
5/7/13 Q113 -$0.03-$0.01 -$0.02$7M$5.83M N/A Details